Laura Squarzon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Laura Squarzon has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Giorgio Palù
Department of Molecular Medicine, University of Padova, 35121 Padova, Italy
4 shared publications - Luisa Barzon
Department of Molecular Medicine, University of Padova, Padua, Italy
4 shared publications - Elisa Franchin
Department of Molecular Medicine, University of Padua, 35121 Padua, Italy
3 shared publications - Enrico Lavezzo
Department of Molecular Medicine, University of Padua, Padua, Italy
3 shared publications - Monia Pacenti
Department of Molecular Medicine, University of Padua, Via A. Gabelli, 63 35121 Padua, PD, Italy
3 shared publications - Riccardo Cusinato
Regional Reference Laboratory for Infectious Diseases, Microbiology and Virology Unit, Padova University Hospital, Padova I-35128, Italy
3 shared publications
Latest Publications
- Open Access
Large Human Outbreak of West Nile Virus Infection in North-Eastern Italy in 2012
Human cases of West Nile virus (WNV) disease have been reported in Italy since 2008. So far, most cases have been identified in north-eastern Italy, where, in 2012, the largest outbreak of WNV infection ever recorded in Italy occurred. Most cases of the 2012 outbreak were identified in the Veneto region, where a special surveillance plan for West Nile fever was in place. In this outbreak, 25 cases of West Nile neuroinvasive disease and 17 cases of fever were confirmed. In addition, 14 WNV RNA-positive blood donors were identified by screening of blood and organ donations and two cases of asymptomatic infection were diagnosed by active surveillance of subjects at risk of WNV exposure. Two cases of death due to WNND were reported. Molecular testing demonstrated the presence of WNV lineage 1 in all WNV RNA-positive patients and, in 15 cases, infection by the novel Livenza strain was ascertained. Surveillance in other Italian regions notified one case of neuroinvasive disease in the south of Italy and two cases in Sardinia. Integrated surveillance for WNV infection remains a public health priority in Italy and vector control activities have been strengthened in areas of WNV circulation.
Open AccessLarge Human Outbreak of West Nile Virus Infection in North-Eastern Italy in 2012
Human cases of West Nile virus (WNV) disease have been reported in Italy since 2008. So far, most cases have been identified in north-eastern Italy, where, in 2012, the largest outbreak of WNV infection ever recorded in Italy occurred. Most cases of the 2012 outbreak were identified in the Veneto region, where a special surveillance plan for West Nile fever was in place. In this outbreak, 25 cases of West Nile neuroinvasive disease and 17 cases of fever were confirmed. In addition, 14 WNV RNA-positive blood donors were identified by screening of blood and organ donations and two cases of asymptomatic infection were diagnosed by active surveillance of subjects at risk of WNV exposure. Two cases of death due to WNND were reported. Molecular testing demonstrated the presence of WNV lineage 1 in all WNV RNA-positive patients and, in 15 cases, infection by the novel Livenza strain was ascertained. Surveillance in other Italian regions notified one case of neuroinvasive disease in the south of Italy and two cases in Sardinia. Integrated surveillance for WNV infection remains a public health priority in Italy and vector control activities have been strengthened in areas of WNV circulation.
- Open Access
- 30 September 2013
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 10 (10) , 4669-4689
The Complex Epidemiological Scenario of West Nile Virus in Italy
Entomological, veterinary, and human surveillance systems for West Nile virus (WNV) infection have been implemented in Italy since the first detection of the virus in 1998. These surveillance activities documented a progressive increase of WNV activity and spread in different regions and the emergence of new WNV lineages and strains. Italy is a paradigmatic example of the complex epidemiology of WNV in Europe, where sporadic cases of WNV infection, clusters, and small outbreaks have been reported in several regions. In addition, different strains of both WNV lineage 1 and lineage 2 have been identified, even co-circulating in the same area.
- 30 September 2013
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 10 (10) , 4669-4689
Open AccessThe Complex Epidemiological Scenario of West Nile Virus in Italy
Entomological, veterinary, and human surveillance systems for West Nile virus (WNV) infection have been implemented in Italy since the first detection of the virus in 1998. These surveillance activities documented a progressive increase of WNV activity and spread in different regions and the emergence of new WNV lineages and strains. Italy is a paradigmatic example of the complex epidemiology of WNV in Europe, where sporadic cases of WNV infection, clusters, and small outbreaks have been reported in several regions. In addition, different strains of both WNV lineage 1 and lineage 2 have been identified, even co-circulating in the same area.
- Open Access
Genome Sequencing of West Nile Virus from Human Cases in Greece, 2012
A West Nile Virus (WNV) lineage 2 strain, named Nea Santa-Greece-2010, has been demonstrated to be responsible for the large outbreaks of neuroinvasive disease (WNND) that have been occurring in Greece since 2010, based on sequence similarities of viral isolates identified between 2010–2012. However, knowledge on the evolution of this strain is scarce because only partial WNV genome sequences are available from Greece. The aim of this study was to get the complete genome sequence of WNV from patients with infection. To this aim, plasma and urine samples collected during the 2012 Greek outbreak were retrospectively investigated. Full WNV genome sequence was obtained from a patient with WNND. The genome had 99.7% sequence identity to Nea Santa, higher than to other related WNV lineage 2 strains, and five amino acid changes apparently not relevant for viral pathogenicity or fitness. In addition, infection by WNV lineage 2 was confirmed in additional nine patients with WNND; in three of them the infection with WNV Nea Santa was demonstrated by sequencing. In conclusion, this study characterized for the first time a WNV full genome from a patient with WNND from Greece, demonstrated the persistence of the Nea Santa strain, and suggested that the virus might have locally evolved.
Open AccessGenome Sequencing of West Nile Virus from Human Cases in Greece, 2012
A West Nile Virus (WNV) lineage 2 strain, named Nea Santa-Greece-2010, has been demonstrated to be responsible for the large outbreaks of neuroinvasive disease (WNND) that have been occurring in Greece since 2010, based on sequence similarities of viral isolates identified between 2010–2012. However, knowledge on the evolution of this strain is scarce because only partial WNV genome sequences are available from Greece. The aim of this study was to get the complete genome sequence of WNV from patients with infection. To this aim, plasma and urine samples collected during the 2012 Greek outbreak were retrospectively investigated. Full WNV genome sequence was obtained from a patient with WNND. The genome had 99.7% sequence identity to Nea Santa, higher than to other related WNV lineage 2 strains, and five amino acid changes apparently not relevant for viral pathogenicity or fitness. In addition, infection by WNV lineage 2 was confirmed in additional nine patients with WNND; in three of them the infection with WNV Nea Santa was demonstrated by sequencing. In conclusion, this study characterized for the first time a WNV full genome from a patient with WNND from Greece, demonstrated the persistence of the Nea Santa strain, and suggested that the virus might have locally evolved.
- Open Access
- 15 April 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (8) , 1276-1277
Reply to Maggi et al
To the Editor—We wish to reply to the comments of Maggi et al [1] on our recent study [2]. At variance with our findings [2, 3], these investigators did not detect any WU and KI polyomavirus (WUPyV and KIPyV) sequences or Merkel cell carcinoma and lymphotropic polyomavirus sequences in brain biopsy, cerebrospinal fluid, or peripheral blood samples obtained from 7 human immunodeficiency virus (HIV)-negative patients with JC polyomavirus-associated progressive multifocal leukoencephalopathy (Focosi et al [4]). As suggested by Maggi et al [1], the absence of the newly discovered polyomaviruses in the brains of HIV-negative patients seems to support the hypothesis that WUPyV and KIPyV reactivate and are detectable in the brains and other tissues of immunosuppressed subjects, such asHIVinfected patients [ , 5, 6]. However, technical aspects need to be taken into consideration when comparing the results of the 2 studies. In particular, stereotactic brain biopsy samples were analyzed in Focosi et al [4], which were probably smaller than the large samples we could obtain at autopsy from multiple brain areas, thus increasing the sensitivity of our polymerase chain reaction method [2].
- 15 April 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (8) , 1276-1277
Open AccessReply to Maggi et al
To the Editor—We wish to reply to the comments of Maggi et al [1] on our recent study [2]. At variance with our findings [2, 3], these investigators did not detect any WU and KI polyomavirus (WUPyV and KIPyV) sequences or Merkel cell carcinoma and lymphotropic polyomavirus sequences in brain biopsy, cerebrospinal fluid, or peripheral blood samples obtained from 7 human immunodeficiency virus (HIV)-negative patients with JC polyomavirus-associated progressive multifocal leukoencephalopathy (Focosi et al [4]). As suggested by Maggi et al [1], the absence of the newly discovered polyomaviruses in the brains of HIV-negative patients seems to support the hypothesis that WUPyV and KIPyV reactivate and are detectable in the brains and other tissues of immunosuppressed subjects, such asHIVinfected patients [ , 5, 6]. However, technical aspects need to be taken into consideration when comparing the results of the 2 studies. In particular, stereotactic brain biopsy samples were analyzed in Focosi et al [4], which were probably smaller than the large samples we could obtain at autopsy from multiple brain areas, thus increasing the sensitivity of our polymerase chain reaction method [2].
- Open Access
- 30 June 2008
- Published by PAGEPress Publications in Microbiologia Medica
- Vol. 23 (2)
Utilization of the chromogenic agar MRSA ID in the surveillance of methicillin-resistant Staphylococcus aureus in a low endemic unit for MRSA
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common pathogen responsible for nosocomial infections.Approximately 20% of patients undergoing surgical operations acquires at least one nosocomial infection. Nasal carriers of S. aureus have been identified as one of the populations at major risk to develop this type of infection, particularly, after operations, dialysis, transplants and admission in intensive care unit. Our study was conducted on patients who came from a Neurosurgery Intensive Care Unit, where the incidence of MRSA is very low (8%) and where it is very important to identify MRSA carriers in order to adopt measures to avoid transmission.The use of chromogenic agar MRSA ID allowed us to identify green colonies of MRSA within 24 hours and to make a timely and careful diagnosis.
- 30 June 2008
- Published by PAGEPress Publications in Microbiologia Medica
- Vol. 23 (2)
Open AccessUtilization of the chromogenic agar MRSA ID in the surveillance of methicillin-resistant Staphylococcus aureus in a low endemic unit for MRSA
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common pathogen responsible for nosocomial infections.Approximately 20% of patients undergoing surgical operations acquires at least one nosocomial infection. Nasal carriers of S. aureus have been identified as one of the populations at major risk to develop this type of infection, particularly, after operations, dialysis, transplants and admission in intensive care unit. Our study was conducted on patients who came from a Neurosurgery Intensive Care Unit, where the incidence of MRSA is very low (8%) and where it is very important to identify MRSA carriers in order to adopt measures to avoid transmission.The use of chromogenic agar MRSA ID allowed us to identify green colonies of MRSA within 24 hours and to make a timely and careful diagnosis.